Letters to the Editor

Minimal residual disease assessment in transplant-eligible patients with multiple myeloma: real-world applications of multiparametric flow cytometry-DURAClone (CAREMM-2104)

Department of Laboratory Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Centre, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
Department of Haematology, Catholic Haematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Haematology, Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Centre, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
Department of Haematology, Catholic Haematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Haematology, Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Centre, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Centre, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Centre, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
Department of Haematology, Catholic Haematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Haematology, Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul
Haematologica Early view Jul 18, 2024 https://doi.org/10.3324/haematol.2024.285278